Network Insights Methodology Whitepaper Get Access

Merck

ORG Health Care / Pharmaceuticals Momentum 21.0ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$60.1B revenue (2025), Rahway-based pharmaceutical giant acquired Bio-Techne for $11.3B to bolster life sciences and diagnostics capabilities. Steep price cuts on Hep C drug Zepatier signal competitive pressure and payer pushback on specialty pharma margins.

Announced acquisition of U.S.-based Bio-Techne Corp. for $11.3 billion in cash, expanding life sciences tools portfolio. Concurrent pricing action on Hepatitis C drug Zepatier.
0.11
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
21.0
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
8
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Merck is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Novartis China Eli Lilly PlocamiumAI AstraZeneca FDA Washington India European Union HHS Robert F. Kennedy Jr. Paris Reuters Bloomberg New Jersey
Watch This Entity
PSI Intelligence
30-Day Trend
2026-06-07 2026-07-07 8 0 Degree Mentions
Signal Decomposition
Attention Cascade
3.332
Narrative Drift
0.000
Spectral Shift
687.846
Sentiment-Momentum Divergence
0.000
Source Concentration
0.909
Signal
Merck is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #13 of 79 in Health Care — in line with sector peers. PSI stable vs yesterday (0.20).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
13 of 79
Sector Rank
+0.96
Peer Z-Score
85%
Sector Percentile
Network Analysis
8 Degree Centrality
Ego Network (top connections)
Novartis (weight 111.0)China (weight 16.0)Eli Lilly (weight 12.0)PlocamiumAI (weight 11.0)AstraZeneca (weight 8.0)FDA (weight 8.0)Washington (weight 6.0)India (weight 4.0) NovartisChinaEli LillyPlocamiumAIAstraZenecaFDAWashingtonIndia Merck (degree 8) Merck
Centrality History
2026-06-07 2026-07-07 8 0 Degree Mentions
EntityWeight StatusFirst Seen
Novartis 111 NEW
China 16 STABLE
Eli Lilly 12 NEW
PlocamiumAI 11 NEW
AstraZeneca 8 NEW
FDA 8 STABLE
Washington 6 STABLE
India 4 STABLE
European Union 3 STABLE
HHS 2 STABLE
Robert F. Kennedy Jr. 2 NEW
Paris 2 NEW
Reuters 2 STABLE
Bloomberg 2 STABLE
New Jersey 2 NEW
Novo Nordisk 2 NEW
Dr 1 NEW
EPA 1 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-07-07 ← Intelligence Network